Climb Bio, Inc. Common Stock

CLYMNASDAQUSD
7.11 USD
0.23 (3.35%)🔴AT CLOSE (AS OF 07:21 PM EDT)
🔴Market: CLOSED
Open?$7.10
High?$7.29
Low?$6.84
Prev. Close?$6.87
Volume?363.9K
Avg. Volume?565.2K
VWAP?$7.07
Rel. Volume?0.64x
Bid / Ask
Bid?$6.06 × 100
Ask?$8.19 × 100
Spread?$2.13
Midpoint?$7.13
Valuation & Ratios
Market Cap?339.2M
Shares Out?47.8M
Float?32.0M
Float %?67.1%
P/E Ratio?N/A
P/B Ratio?2.11
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.16Strong
Quick Ratio?15.16Strong
Cash Ratio?5.11Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.11CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-4.5CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-37.3%WEAK
ROA?
-35.7%WEAK
Cash Flow & Enterprise
FCF?$-54542000
Enterprise Value?$303.5M
Related Companies
Loading...
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Employees
29
Market Cap
339.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596